Destroying Tumor Cells: Targeted Immunotherapy Using Injectable Materials (IMAGE)

Terasaki Institute for Biomedical Innovation

Destroying Tumor Cells: Targeted Immunotherapy Using Injectable Materials

Caption

Researchers have developed a method for injectable, targeted delivery of immunotherapeutic treatments. The shear-thinning biomaterial is loaded with the ICI, which can then be delivered and released at the tumor site. The ICIs bind to T cells, preventing binding and T cell suppression by the tumor cells. This frees the T cells to seek and attack the tumor cells.

Credit

Terasaki Institute for Biomedical Innovation (TIBI)

Usage Restrictions

Please obtain permission from Terasaki Institute for Biomedical Innovation (TIBI)

License

Original content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.